Outcome of Colorectal Cancer Patients Treated with Combination Bevacizumab Therapy: A Pooled Retrospective Analysis of Three European Cohorts from the Angiopredict Initiative

Publisher： Karger

E-ISSN： 1421-9867|94|3|129-137

ISSN： 0012-2823

Source： Digestion, Vol.94, Iss.3, 2016-10, pp. : 129-137

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Role of Primary Tumor Resection Among Chemotherapy-Treated Patients with Synchronous Stage IV Colorectal Cancer: A Survival Analysis

By Tsang Walter   Ziogas Argyrios   Lin Bruce   Seery Tara   Karnes William   Stamos Michael   Zell Jason  

Journal of Gastrointestinal Surgery, Vol. 18, Iss. 3, 2014-03 ,pp. : 592-598

Springer Publishing Company

Access to resources Recommend Favorite

Single-Agent Irinotecan for Recurrent/Metastatic Colorectal Cancer: A Retrospective Analysis

By  

Medical Principles and Practice, Vol. 15, Iss. 4, 2006-06 ,pp. : 288-292

Karger

Access to resources Recommend Favorite

A Case of Long Partial Response to Combination Therapy of Bevacizumab and Capecitabine for Liver Metastases of Rectal Cancer

By  

Case Reports in Gastroenterology, Vol. 5, Iss. 1, 2011-01 ,pp. : 28-32

Karger

Access to resources Recommend Favorite

Clubbing and Hypertrophic Osteoarthropathy in Two Patients Taking Long-Term Bevacizumab for Metastatic Colorectal Cancer

By Pracht Marc  

Journal of Gastrointestinal Cancer, Vol. 42, Iss. 3, 2011-09 ,pp. : 176-178

Springer Publishing Company

Access to resources Recommend Favorite

FOLFIRI Combined with Bevacizumab as First-Line Treatment for Metastatic Colorectal Cancer Patients with Hyperbilirubinemia after UGT1A1 Genotyping

By  

Medical Principles and Practice, Vol. 23, Iss. 5, 2014-03 ,pp. : 478-481

Karger

Access to resources Recommend Favorite